[HTML][HTML] Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies—need for data validation of the completed trials and to …
VR Emani, S Goswami, D Nandanoor, SR Emani… - International journal of …, 2021 - Elsevier
During this emerging COVID-19 pandemic, initially there were no proven treatment options.
With the release of randomized controlled trial results, we are beginning to see possible …
With the release of randomized controlled trial results, we are beginning to see possible …
Increasing SARS-CoV2 cases, hospitalizations, and deaths among the vaccinated populations during the Omicron (B. 1.1. 529) variant surge in UK
…, S Panga, NK Reddy, NK Reddy, D Nandanoor… - medRxiv, 2022 - medrxiv.org
BACKGROUND There were increased SARS-CoV2 hospitalizations and deaths noted during
Omicron (B.1.1.529) variant surge in the UK despite decreased cases, and the reasons are …
Omicron (B.1.1.529) variant surge in the UK despite decreased cases, and the reasons are …
[HTML][HTML] Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B. 1.617. 2 (Delta variant) outbreak in the United Kingdom
…, NK Reddy, KR Maddula, D Nandanoor… - Journal of Global …, 2022 - ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) was associated with a significantly increased mortality among …
syndrome coronavirus 2) was associated with a significantly increased mortality among …
Changing dynamics of SARS-CoV2 B. 1.617. 2 (Delta variant) outbreak in the United Kingdom: Shifting of SARS-CoV2 infections from younger to elderly populations …
…, KR Maddula, NK Reddy, NK Reddy, D Nandanoor… - medRxiv, 2022 - medrxiv.org
Background To assess the comprehensive dynamics of outcomes during the SARS-CoV2 B.1.617.2
(Delta variant) compared to the Alpha variant outbreak in the United Kingdom. …
(Delta variant) compared to the Alpha variant outbreak in the United Kingdom. …
SARS-Cov2 breakthrough infections in elderly third booster and vaccinated population considered vaccine immune during omicron (B. 1.1. 529) variant surge in Israel
VR Emani, D Nandanoor, R Reddy, AS Nakka… - Current Trends in …, 2022 - abap.co.in
The fourth booster vaccination was approved in Israel during Omicron (B. 1.1. 529) variant
surge due to increasing SARS-CoV2 breakthrough infections among recently vacci-nated …
surge due to increasing SARS-CoV2 breakthrough infections among recently vacci-nated …
[HTML][HTML] Review 1:" Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial …
…, R Reddy, D Nandanoor… - Rapid …, 2022 - rapidreviewscovid19.mitpress.mit …
SUMMARYBackgroundTocilizumab is a monoclonal antibody that binds to the receptor for
interleukin (IL)-6, reducing inflammation, and is commonly used to treat rheumatoid arthritis. …
interleukin (IL)-6, reducing inflammation, and is commonly used to treat rheumatoid arthritis. …
[HTML][HTML] Changing dynamics of COVID-19 deaths during the SARS-CoV2 B. 1.617. 2 (Delta variant) outbreak in England and Wales: Reduced COVID-19 deaths …
…, AS Nakka, NK Reddy, D Nandanoor… - Journal of the …, 2022 - ncbi.nlm.nih.gov
Changing Dynamics of COVID-19 Deaths During the SARS-CoV2 B.1.617.2 (Delta Variant)
Outbreak in England and Wales: Reduced COVID-19 Deaths Among the Care Home …
Outbreak in England and Wales: Reduced COVID-19 Deaths Among the Care Home …
[CITATION][C] POST-ACUTE AND LONG-TERM CARE
CA Estabrooks, HY Jung, H Yun, E O'Donnell… - 2022